Introduction
Esophageal cancer (EC) has been ranked as the eighth most common cancer and the sixth leading cause of cancer-related deaths worldwide. 1 Its epidemiology varies widely, particularly in incidence rates among geographic regions. 2 The latest epidemiological studies indicated the highest rate of EC located on the "esophageal cancer belt" ie, China, South Africa, and France. 3, 4 Possible risk factors for EC include alcohol drinking, hot-temperature food items, cigarette smoking, chronic mucosal irritation, and a family history of cancers. [5] [6] [7] Deficiency of nutrients, such as vitamins and microelements, was also found to be associated with an increased risk of EC, whereas a high intake of fruit and vegetables has been considered to be effective in prevention. 6 Several previous research studies have evaluated the effect of beta-carotene, vitamin A, C, and E on EC. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Regarding multivitamin B, most studies only examined folate
Materials and methods

Search strategy
We conducted a systematic search for published articles and abstracts that evaluated the relationships between B vitamins (B1, B2, B3, B5, B6, B9, B12) and the risk of esophageal carcinoma in humans.
We conducted systemic searches of PubMed (Medline), ScienceDirect, and Cochrane Library electronic databases (from database inception to December 2017). The searches were performed using ((((cohort studies) OR case-control studies)) AND (((((((((((((vitamin B) OR vitamin B1) OR vitamin B2) OR vitamin B3) OR vitamin B5) OR vitamin B6) OR vitamin B9) OR vitamin B12) OR thiamin) OR riboflavin) OR pyridoxal) OR folate) OR cyanocobalamin)) AND (((((cancer) OR neoplasm) OR carcinoma)) AND Esophag*) in all fields. In addition, we scrutinized references from relevant original reports, review articles, and meta-analyses to identify other appropriate studies.
inclusion criteria
In order to be included, the following criteria were needed: 1) the study was designed as a cohort, nested case-control or case-control study; 2) the study reported vitamin B and any kind of B vitamin group intake and the risk of EC; 3) the results reported effect estimates (RR, OR) and 95% CIs for comparisons between high and low dietary vitamin B intake. When multiple levels of vitamin B intake were presented, the ratio comparing the highest intake vs the lowest intake was chosen. When data from several publications were overlapping, we selected the articles with the most comprehensive data for inclusion in this meta-analysis.
Data extraction and quality assessment
Two researchers independently reviewed titles and abstracts of potentially eligible research identified by the search strategy and extracted the date using a standard extraction form from each included publication: the first author's name, publication year, source of control, study design, country where the study was performed, type of cancer, specific vitamin measured, number of cases, number of controls or cohort size, total sample size, lowest vitamin B level, highest vitamin B level, difference between the highest and lowest vitamin B levels, and the risk estimates on EC and corresponding 95% CIs for the highest vs lowest categories of vitamin B intake or for each category, factors adjusted for. Adjusted ratios were extracted in preference to non-adjusted ratios.
Two authors independently assessed the quality of included studies using the Newcastle-Ottawa Scale (NOS), which is a validated scale for assessing the quality of nonrandomized studies in meta-analyses. 18, 19 This scale awards a maximum of 9 points to each study: 4 for selection of participants and measurement of exposure, 2 for comparability of cohorts on the basis of the design or analysis, and 3 for evaluation of methodological quality outcomes. We assigned scores of 7 or higher to high-quality studies.
20,21
Statistical analyses
In this meta-analysis, we calculated effect estimates (RR or OR) and 95% CIs in each study to evaluate the relationship between vitamin B intake and the risk of EC. We used a fixed effects model (Mantel-Haenszel method) when heterogeneity was negligible, and a random effects model (DerSimonian and Laird method) when heterogeneity was significant. Heterogeneity was assessed using I 2 statistic. Significant heterogeneity was indicated if I 2 values were greater than 50%. 22, 23 We also performed a sensitivity analysis by removing individual studies from the meta-analysis when statistically significant heterogeneity was detected. We also used Egger's and Begg's tests to assess publication bias. 24, 25 All tests were two-sided and results were regarded as statistically significant if P<0.05. All statistical analyses were done by using STATA software (version 12.0; StataCorp LP, College Station, TX, USA). Figure 1 shows the literature search results and screening of this study. We identified 390 observational studies from PubMed (Medline), ScienceDirect, and Cochrane Library. A total of 332 articles were assessed after eliminating 58 duplicate papers. A total of 268 articles were excluded owing to reported irrelevant results after reviewing the title and abstract. In addition, three additional studies were found by a manual search of the reference lists. In total, full text of 67 articles was reviewed. Among them, 13 studies did not show the association of vitamin B and EC risk, because these 13 articles explored the relationship between nutrient intervention or mineral compound vitamin B or all the nutrient intake and risk of EC or precancerous lesions. Four articles did not report sufficient data for estimation of OR/RR, three articles did not separately report the 95% CI, nine articles were 
Results
Literature search
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Dietary vitamin B intake and the risk of eC: a meta-analysis reviews, 12 articles reported the prognosis of EC patients, five articles focused on gene type and vitamin B exposures, and two articles focused on blood vitamin B9, B12. As a result, 19 articles were finally selected for the meta-analysis. 8, 9, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] Characteristics and quality of included studies
We identified 19 articles in our study. Tables 1 and 2 show the main characteristics extracted from included studies. All the studies were conducted in Asia, Europe, America, and Australia and were published from 1988 to 2017. Among all the studies, one study was a cohort study 42 and 18 studies were case-control studies. 8, 9, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] The quality of all studies was assessed by using the NOS scale. The overall methodological quality of articles is presented in Table 1 . Overall, eleven studies had a score of 8, 26, 27, 30, 32, 33, [35] [36] [37] [38] [39] [40] four had a score of 7, 8, 9, 34, 42 and the remaining studies had a score of 6. 
vitamin B1 intake
The association between vitamin B1 intake and EC risk was It was not possible to perform dose-response meta-analyses due to limited data.
vitamin B2 intake
We did not observe a statistically significant association for vitamin B2 supplements and EC risk (Figure 3 , OR=0.86; 95% CI: 0.64-1.16) based on eleven studies. There was Mayne (2001) Mayne (2001) Jessri (2011) Ibiebele (2011) Ibiebele (2011) 
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Ma et al statistically significant heterogeneity among the studies on dietary vitamin B2 intake (I 2 =70.2%; P<0.001).
vitamin B3 intake
As shown in Figure 4 , seven studies examined the association between vitamin B3 intake and EC risk. The pooled OR for the highest vs lowest vitamin B3 intake was 0.70 (95% CI: 0.53-0.94, I 2 =53.9%, P=0.043). Dose-response metaanalyses were not done due to data limitations.
vitamin B5 intake
There was only one study which showed the association between vitamin B5 intake and EC risk (OR=0.49, 95% CI:0.20-1.20), suggesting that vitamin B5 intake was not significantly associated with the risk of EC.
vitamin B6 intake
A total of 13 studies assessed the association between dietary vitamin B6 intake and EC risk. Figure 5 shows that the pooled OR of EC risk for the highest vs the lowest categories of vitamin B6 intake was 0.64 (95% CI: 0.49-0.83, I 2 =73.0%, P=0.00), indicating that vitamin B6 intake had a protective Mayne (2001) Mayne (2001) Chen (2009) Jessri (2011) Ibiebele (2011) Ibiebele (2011) Sharp (2013) Bao (2013) Fanidi (2014) Fanidi ( 
vitamin B9 intake
The association between dietary folate intake and EC risk was examined in 15 studies. The multivariable adjusted ORs for each study and combination of all studies for the highest vs lowest level of dietary folate intake are shown in Figure 6 . The pooled OR of EC for the highest vs lowest level of dietary folate intake was 0.63 (95% CI: 0.56-0.71). There was statistically significant heterogeneity among the studies on dietary folate intake (I 2 =70.2%; P=0.00). Dose-response meta-analysis was based on seven studies. A statistically significant, inverse association was observed for an increase of 100 µg/day in supplemental vitamin B9 and EC risk (OR=0.89; 95% CI: 0.86-0.94).
vitamin B12 intake
Inconsistent associations were observed for use of vitamin B12 supplements and EC risk in our study (OR=1.34, 95% 
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Dietary vitamin B intake and the risk of eC: a meta-analysis Mayne (2001) Mayne (2001) Chen (2009) Jessri (2011) Ibiebele (2011) Ibiebele ( Mayne (2001) Galeone (2006) Chen (2009) Jessri (2011) Ibiebele (2011) Sharp (2013) Xiao (2014) Xiao (2014) Fanidi (2014) Fanidi ( Figure 7 . Using restricted cubic spline function, we found a potential non-linear dose-response association between dietary vitamin B12 intake and EC risk (P non-linearity = 0.0001) (Figure 8 ). The non-linear curve showed that there was a dose-response association between vitamin B12 dose and decreased risk of EC approximately below 5.5 µg/day, whereas the EC risk did not decrease further above 5.5 µg/day.
Publication bias
Publication bias was evaluated by Egger's 24 and Begg's tests. 25 The results disclosed no evidence of publication bias for EC (Egger: t=0.38, P=0.575; Begg: z=1.34 P=0.179 ).
Sensitivity analysis
As a result, a sensitivity analysis of multivitamin B intake was conducted, and after each study was sequentially excluded from the pooled analysis, the conclusion was not affected by exclusion of any specific study.
Discussion
Epidemiological investigations have suggested that there are significant relationships between diet-associated factors and EC. B vitamins may be one factor. Because some B vitamins cannot be synthesized in the human body, they can only be obtained through dietary. Fruit and vegetables are important dietary sources of some B vitamins. The reason why vitamin Mayne (2001) Mayne (2001) Bollschweiler (2002) Bollschweiler (2002) Yang (2005) Galeone (2006) Qin (2008) Chen (2009) Zhao (2011) Jessri (2011) lbiebele (2011) lbiebele (2011) Aune (2011) Tavani (2012) Ling (2013) Sharp (2013) Bao (2013) Xiao (2014) Xiao (2014) Fanidi (2014) Fanidi ( 
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Dietary vitamin B intake and the risk of eC: a meta-analysis B affects the risk of cancer may be because it is essential for the biosynthesis of nucleotides, replication of DNA, supply of methyl groups, and the growth and repair of cells. [43] [44] [45] [46] In the present review, there was no epidemiologic research that assessed the association between total B vitamin consumption and EC risk among people. There were only studies which evaluated the relationship between several subclasses of B vitamins and EC risk. Thus, this study is the most comprehensive meta-analysis providing evidence to indicate these results. We found that total vitamin B intake was significantly associated with reduced EC risk. In addition, we evaluated the potential association of vitamin B subclasses and EC risk, respectively. In the subgroup analysis, we found that vitamin B1, B3, B6, and B9 may be protective factors, but vitamin B12, in contrast, was positively associated with risk of EC.
Previous studies have shown that consuming large quantities of vegetables, fruit, vitamins, and antioxidants can reduce the risk of EC. [47] [48] [49] One potential reason for vitamin B12 being different from other B vitamins may be because it is derived exclusively from foods of animal origin, and it is simply a marker for consumption of animal protein. In previous studies, the risk of adenocarcinomas of the esophagus was linked to high-fat diets 50, 51 because esophageal adenocarcinoma generally arises from Barrett's epithelium. 52 Additionally, research has shown that diets low in animal protein and rich in fruit, vegetables, and fiber can reduce the risk of malignant transformation. 33 Mayne (2001) Jessri (2011) lbiebele (2011) lbiebele (2011) Sharp (2013) Xiao (2014) Xiao (2014) Fanidi (2014) Fanidi (2014) Chang (2015) Note: weights are from random effects analysis 
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Ma et al B-group vitamin supplementation may have antioxidant and anti-inflammatory effects. 53, 54 The biological mechanisms responsible for the protective effect of high-dosage vitamin B are unclear. One possible explanation is that B vitamins and additional nutrients sourced from fruit and vegetables are involved in the one-carbon metabolism. [55] [56] [57] The metabolic pathway of one-carbon metabolism has been frequently implicated in carcinogenesis, because of its involvement in maintaining nucleotide biosynthesis and methylation reactions. Imbalances and deficiencies among crucial one-carbon metabolism nutrients may interfere with DNA replication, DNA repair, and regulation of gene expression, any of which could promote carcinogenesis. 58, 59 Like the vitamin B3, vitamin B6 and vitamin B9, they are indispensable in the biosynthesis of four bases of DNA (thymidine, guanine, adenine, and cytosine). Deficiency of one or more of the three vitamins required for DNA maintenance is known to cause abnormal pairing of the four bases, which can then result in mutations and the development of cancer. 60 Intake of vitamin B6 was reported to increase immunoglobulin G and T4(helper) lymphocytes in humans. 61 Folate deficiency was suggested to be related to increased carcinogenesis, an effect that may be mediated through participation in methyl metabolism.
62
Limitations
There were some limitations in our study that should be addressed. First, most studies included in our analysis were case-control studies, which may have caused recall bias, and could have caused potential heterogeneity, although the methodological quality of these observational studies was medium to high. More prospective cohort studies are needed to test this association. Second, it was a challenge to evaluate the quantity of vitamin B intake accurately because vitamin B can be sourced from various food types, and may be influenced by the type of cultivation, crop variety and location, as well as the specific morphological part of the plant eaten.
In conclusion, results from the present meta-analysis indicate that vitamin B intake is inversely associated with EC risk.
Conclusion
Our findings support that vitamin B may have an influence on carcinogenesis of the esophagus. Vitamin B1, B3, B6, and B9 showed a decreased risk of EC, vitamin B12 showed an increased risk of EC. (It is clear that scientists must apply the very best science in characterizing the safety of vitamin supplements.)
